CienciaChina’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

pendiente de traducción

Akesoivonescimabbiliary tract cancerclinical trial

SSouth China Morning Post★★★☆☆2026-08-27 02:07Original